Chemotherapy-induced Acute or Delayed Nausea and Vomiting (CINV)
2
0
0
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
3 treatments under study, led by Granisetron
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 2 trials
100.0%
+13.4% vs benchmark
100%
2 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (2)
Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in Chemotherapy-induced Nausea and Vomiting Associated With the Administration of Highly Emetogenic Chemotherapy (HEC)
Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in CINV (Chemotherapy-induced Nausea and Vomiting) Associated With the Administration of MEC (Moderately Emetogenic Chemotherapy)
Research Network
Common Treatments
- Granisetron2
- Kytril Injkytril Tab1
- Zofran Injzofran Tab1
Active Sponsors
- LG Life Sciences2
Top Investigators
St Vincent's Hospital
Daejeon St. Mary's hospital
Yeouido St. Mary's Hospital
Seoul St'. Mary's Hospital
Bucheon St. Mary's Hospital